Company Filing History:
1 out of 832,891 Years Active: 2019
Title: Innovations in Alzheimer's Treatment by Chih-Li Lin
Introduction
Chih-Li Lin is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. His innovative approach utilizes microRNAs as therapeutic agents, showcasing the potential of genetic engineering in medicine.
Latest Patents
Chih-Li Lin holds a patent for a composition and method of using miR-302 precursors as drugs for treating Alzheimer's disease. This invention relates to the use of recombinant microRNAs (miRNA) and their hairpin-like precursors (pre-miRNA) as therapeutic drugs. Specifically, it focuses on the application of man-made miRNA miR-302 precursors for Alzheimer's therapy in humans. The invention outlines a method for mass-producing these pre-miR-302 molecules in prokaryotic cells, which do not transcribe or process hairpin-like RNAs. This novel approach also introduces a unique hairpin-like RNA transcription mechanism found in prokaryotes. The implications of this research extend beyond Alzheimer's, potentially aiding in the treatment of other age-related degenerative diseases.
Career Highlights
Chih-Li Lin's career is marked by his dedication to advancing medical science through innovative research. His work on miR-302 precursors has positioned him as a key figure in the development of regenerative medicine. His findings not only contribute to Alzheimer's treatment but also pave the way for addressing other conditions such as Parkinson's disease, osteoporosis, diabetes, and various cancers.
Collaborations
Chih-Li Lin has collaborated with notable colleagues, including Hsin-Hua Li and Shi-Lung Lin. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation.
Conclusion
Chih-Li Lin's contributions to the field of Alzheimer's treatment through his innovative use of miR-302 precursors highlight the potential of genetic research in medicine. His work exemplifies the intersection of science and technology, offering hope for future advancements in treating degenerative diseases.